Oaktree Acquisition Corp. III (OACC) is a specialized acquisition vehicle focused on identifying and merging with innovative companies in the life sciences sector. With a management team boasting extensive experience in healthcare investments, OACC aims to leverage growth potential across various domains, including healthcare technology, therapeutics, and medical devices. By emphasizing strategic partnerships and rigorous due diligence, the company is well-positioned to enhance shareholder value and navigate the dynamic landscape of the life sciences industry.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -0.38% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.28 |
| Price-to-Book | 1.34 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 115.20% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $19.78M |
| Float | $18.37M |
| % Insiders | 0.00% |
| % Institutions | 90.65% |
Volatility is currently expanding